TY - JOUR
T1 - Novel evasion mechanisms of the classical complement pathway
AU - Garcia, Brandon L.
AU - Zwarthoff, Seline A.
AU - Rooijakkers, Suzan H.M.
AU - Geisbrecht, Brian V.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health (AI111203 and AI113552 to B.V.G.), the Netherlands Scientific Organization (NWO-Vidi 91711379), and the European Research Council (ERC Starting Grant 639209-ComBact to S.H.M.R.).
Publisher Copyright:
Copyright © 2016 by The American Association of Immunologists, Inc.
PY - 2016/9/15
Y1 - 2016/9/15
N2 - Complement is a network of soluble and cell surfaceassociated proteins that gives rise to a self-amplifying, yet tightly regulated system with fundamental roles in immune surveillance and clearance. Complement becomes activated on the surface of nonself cells by one of three initiatingmechanisms known as the classical, lectin, and alternative pathways. Evasion of complement function is a hallmark of invasive pathogens and hematophagous organisms. Althoughmany complement-inhibition strategies hinge on hijacking activities of endogenous complement regulatory proteins, an increasing number of uniquely evolved evasion molecules have been discovered over the past decade. In this review, we focus on several recent investigations that revealed mechanistically distinct inhibitors of the classical pathway. Because the classical pathway is an important and specific mediator of various autoimmune and inflammatory disorders, in-depth knowledge of novel evasion mechanisms could direct future development of therapeutic anti-inflammatory molecules.
AB - Complement is a network of soluble and cell surfaceassociated proteins that gives rise to a self-amplifying, yet tightly regulated system with fundamental roles in immune surveillance and clearance. Complement becomes activated on the surface of nonself cells by one of three initiatingmechanisms known as the classical, lectin, and alternative pathways. Evasion of complement function is a hallmark of invasive pathogens and hematophagous organisms. Althoughmany complement-inhibition strategies hinge on hijacking activities of endogenous complement regulatory proteins, an increasing number of uniquely evolved evasion molecules have been discovered over the past decade. In this review, we focus on several recent investigations that revealed mechanistically distinct inhibitors of the classical pathway. Because the classical pathway is an important and specific mediator of various autoimmune and inflammatory disorders, in-depth knowledge of novel evasion mechanisms could direct future development of therapeutic anti-inflammatory molecules.
UR - https://www.scopus.com/pages/publications/84988961303
U2 - 10.4049/jimmunol.1600863
DO - 10.4049/jimmunol.1600863
M3 - Article
C2 - 27591336
AN - SCOPUS:84988961303
SN - 0022-1767
VL - 197
SP - 2051
EP - 2060
JO - Journal of Immunology
JF - Journal of Immunology
IS - 6
ER -